Datametrex Announces Completion of Private Placement and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
23
Datametrex Announces Completion of Private Placement and Management Changes

TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the “ Company ” or “ Datametrex ”) ( TSXV: DM, FSE: D4G ) announces that it has ended its previously-announced non-brokered private placement (the “ Offering ”) of units (each a “ Unit ”) and that no further tranches will be completed. An aggregate of 22,044,000 Units at a price of $0.05 per Unit were sold under a single tranche on January 25, 2019 for aggregate gross proceeds of $1,102,200.

Each Unit consisted of one common share in the capital of the Company and one common share purchase warrant, with each warrant exercisable into one common share at a price of $0.08 for a period of 18 months after closing of the Offering (the “ Warrant Expiry Date ”). In the event that the volume-weighted average trading price of the common shares on the TSX Venture Exchange equals or exceeds $0.12 per common share for any period of 15 consecutive trading days, the Company may, at its option, within 10 business days following such 15-day period, accelerate the Warrant Expiry Date by issuing a press release (a “ Warrant Acceleration Press Release ”), and, in such case, the Warrant Expiry Date shall be deemed to be 5:00 p.m. (Toronto time) on the 15th day following the issuance of the Warrant Acceleration Press Release. The Company intends to use the aggregate net proceeds of the Offering for research and development and general working capital purposes.

Although the Offering was non-brokered, the Company compensated a dealer that introduced subscribers to the Company (a “ Finder ”) by way of: (i) a cash finder’s fee equal to 8% of the aggregate gross proceeds of the subscribers introduced to the Company by such Finder; and (ii) 564,800 non-transferable common share purchase warrants (on terms identical to those warrants under the Offering), representing 8% of the aggregate Units of the subscribers introduced to the Company by such Finder.

The securities issued in connection with this first tranche of the Offering, including the Finder’s warrants, are subject to a four-month hold period ending on May 26, 2019. Certain insiders of the Company participated in the first tranche of the Offering and purchased an aggregate of $545,000 (10,900,000 Units), which includes $300,000 (6,000,000 Units) from Andrew Ryu, CEO of the Company, and $120,000 (2,400,000 Units) from Jeffrey Stevens, President and COO of the Company. Participation of such insiders in the Offering constituted a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“ MI 61-101 ”), but was exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities issued to the insider nor the consideration paid by the insider exceeded 25% of the Company’s market capitalization. None of the Company’s directors expressed any contrary views or disagreements with respect to the foregoing. The Company did not file a material change report 21 days prior to the closing of the Offering as the details of the participation of insiders of the Company had not been confirmed at that time.

Datametrex also announces that Claude Théoret has resigned as President and a director of Nexalogy Environics (“ Nexalogy ”), a subsidiary of the Company. Marshall Gunter, CEO of Nexalogy, will assume Mr. Théoret’s former responsibilities.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy ( www.nexalogy.com ) and  Implementing Blockchain technology for secure Data Transfers through its investee company, Graph Blockchain ( www.graphblockchain.com ).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Jeffrey Stevens – President & COO Phone: (647) 400-8494 Email: jstevens@datametrex.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains "forward-looking information" within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.

The forward-looking information contained in this press release includes information relating to the potential acceleration of the Warrant Expiry Date and the use of the net proceeds of the Offering. Forward-looking information is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation, those discussed in the Company's current MD&A and Annual Information Form, both of which have been filed on SEDAR and can be accessed at www.sedar.com.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 3

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 2

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 2

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Bay Crane's Bold Auction: A Strategic Fleet Update

Updated Category News Views 2

Bay Crane's Big Move: Strategic Fleet Update through Auction Well, here's a twist that gets the pulse racing for industry folk and machinery buffs. Bay Crane Companies, a powerhouse in the crane and hauling sector, has decided to go all in on a strategic fleet update. And what better way to move that iron than with a live, no-reserve auction? They've tapped Jeff Martin...

Continue Reading
Aviator Nation Teams with NFL for 2026 Collection Launch

Updated Category News Views 3

In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 2

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 3

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 4

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading
Catalina Behavioral Health: 4 Years, 1,000 Lives Touched

Updated Category News Views 3

Pioneering Care in Behavioral Health Catalina Behavioral Health is proving that four years can make a difference. From their base in Tucson, they've grown to serve 1,000 souls navigating the stormy waters of addiction and mental health. It's not just about numbers, you see—this milestone marks real lives changed, one battle at a time. Building Trust, One Patient at a...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Developments Regarding Reconnaissance Energy Securities Case

Updated Category News Views 45

Overview of the Reconnaissance Energy Africa Ltd. Case Recent developments reveal that anyone who bought common stock of Reconnaissance Energy Africa Ltd. or its predecessor, Lund Enterprises Corp., on the U.S. OTC market is now being informed about a certified class action lawsuit. This notice is particularly relevant to those who purchased shares under the ticker...

Continue Reading
Red Violet to Share Exciting Q3 Financial Insights Soon

Updated Category News Views 122

Anticipating Q3 Financial Results from Red Violet Red Violet, Inc. (NASDAQ: RDVT), known for its innovative analytics and information solutions, is set to announce its financial results for the third quarter. This significant milestone will occur after the U.S. financial markets close on a day that promises to offer transparency into the company's recent performance....

Continue Reading
Global Atomic Corporation Secures C$35 Million Offering Increase

Updated Category News Views 125

Global Atomic Corporation's Public Offering Upsized to C$35 Million In a significant move, Global Atomic Corporation is thrilled to announce the upsizing of its public offering to gross proceeds of C$35 million. This decision was spurred by high investor demand, reflecting the growing interest in the company's future prospects. Details of the Offering The previously...

Continue Reading
Aircraft Delivery Delays: Insights from SMBC Aviation's CEO

Updated Category News Views 206

Challenges Facing Aircraft Deliveries The aviation industry is currently grappling with significant delays in aircraft deliveries, as highlighted by Peter Barrett, the CEO of SMBC Aviation Capital. Speaking at a conference, he noted that almost every new aircraft from major manufacturers like Boeing and Airbus is affected. Understanding the Cause of Delays These delivery...

Continue Reading
Alzamend Neuro Preps for Upcoming PTSD Drug Study in 2025

Updated Category News Views 177

Alzamend Neuro's New Study for PTSD Treatment Alzamend Neuro, Inc. has exciting plans on the horizon as it prepares to launch a Phase 2 clinical study of its lead drug, AL001, aimed at helping patients battling post-traumatic stress disorder (PTSD). This study is set to begin in the fourth quarter of 2025, aiming to explore innovative solutions for those affected by this...

Continue Reading